Since Ki67 indicates tumor growth activity, assessment of Ki67 can be used to estimate tumor response to therapies that specifically target dividing cells, such as chemotherapy in particular (Scholzen and Gerdes 2000; Tashima et al. 2015). The gene discussed is MKI67; the disease is neoplasm.